These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31774111)

  • 1. Antithrombotic therapy after acute coronary syndrome and/or percutaneous coronary intervention in atrial fibrillation: finding the sweet spot.
    Lopes RD; Hong H; Alexander JH
    Eur Heart J; 2019 Dec; 40(46):3768-3770. PubMed ID: 31774111
    [No Abstract]   [Full Text] [Related]  

  • 2. Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI.
    Mehta SR
    N Engl J Med; 2019 Apr; 380(16):1580-1581. PubMed ID: 30883051
    [No Abstract]   [Full Text] [Related]  

  • 3. What antithrombotic therapy should I use for my patient with atrial fibrillation who underwent percutaneous coronary intervention or had an acute coronary syndrome?
    Tseng AS; Shamoun FE; Marks LA; Agrwal N
    Cleve Clin J Med; 2021 Jul; 88(7):389-392. PubMed ID: 34210713
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.
    Haller PM; Sulzgruber P; Kaufmann C; Geelhoed B; Tamargo J; Wassmann S; Schnabel RB; Westermann D; Huber K; Niessner A; Gremmel T
    Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):226-236. PubMed ID: 31198930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].
    Yuan C; Zhong L; Huang RC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jun; 45(6):526-535. PubMed ID: 28648031
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.
    Fudim M; Wojdyla DM; Alexander JH; Goodman SG; Mehran R; Windecker S; Aronson R; Vinereanu D; Halvorsen S; Bahit MC; Granger CB; Lopes RD
    J Am Heart Assoc; 2021 Dec; 10(24):e023143. PubMed ID: 34873913
    [No Abstract]   [Full Text] [Related]  

  • 9. The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease - Where Is the Moon Now?
    Effron MB; Gibson CM
    Prog Cardiovasc Dis; 2018; 60(4-5):457-459. PubMed ID: 29366879
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting.
    Wrigley BJ; Tapp LD; Shantsila E; Lip GY
    Pol Arch Med Wewn; 2010 Jul; 120(7-8):290-3. PubMed ID: 20693960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to: Dual vs. triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Golwala H; Cannon CP; Bhatt DL
    Eur Heart J; 2019 Jan; 40(2):218-219. PubMed ID: 30395259
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology.
    Fukamachi D; Hirayama A; Miyauchi K; Yasuda S; Ogawa H; Ito H; Daida H
    J Cardiol; 2018 Aug; 72(2):113-119. PubMed ID: 29599096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic treatment in acute coronary syndrome and atrial fibrillation].
    Darius H; Görge G; Spiecker M; Schinzel H
    Herz; 2019 Feb; 44(1):29-34. PubMed ID: 30689009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    Cardiovasc Interv Ther; 2020 Jan; 35(1):44-51. PubMed ID: 31281936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective.
    Saito Y; Kobayashi Y; Tanabe K; Ikari Y
    Cardiovasc Interv Ther; 2020 Jan; 35(1):19-29. PubMed ID: 31845096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
    Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice.
    Boriani G; Lane DA; Windecker S; Huber K; Kirchhof P; Lip GY
    Europace; 2015 Sep; 17(9):1319-22. PubMed ID: 25678602
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles.
    Patti G; Rubboli A
    Eur J Intern Med; 2017 Jun; 41():e10-e11. PubMed ID: 28365223
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role.
    Alexopoulos D; Vlachakis P; Lekakis J
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):319-324. PubMed ID: 28643219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.